4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine

C161H341N19O15 — CID 157098487

IUPAC4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine
SMILESCC(C)C(C)(C)N1CCOCC1.CC(C)C(C)N1CCC(O)CC1.CC(C)C(C)N1CCOCC1.CC(C)C(C)N1CCO[C@@H](C)C1.CC(C)C(C)N1CCO[C@H](C)C1.CC(C)CN(C)C1COC1.CC(C)CN1CCN(C)CC1.CC(C)CN1CCN(C)CC1(C)C.CC(C)CN1CCNCC1(C)C.CC(C)CN1CCOCC1.CC(C)OC1CCOCC1.CC(C)[C@@H](C)N1CCC(O)CC1.CC(C)[C@@H](C)N1CCC[C@@H](O)C1.CC(C)[C@@H](C)N1CCOCC1.CC(C)[C@H](C)N1CCC(O)CC1.CC(C)[C@H](C)N1CCOCC1.CC1CN(C(C)C(C)C)CCO1
InChIInChI=1S/C11H24N2.C10H22N2.8C10H21NO.C9H20N2.3C9H19NO.2C8H17NO.C8H16O2/c1-10(2)8-13-7-6-12(5)9-11(13,3)4;1-9(2)7-12-6-5-11-8-10(12,3)4;1-9(2)10(3,4)11-5-7-12-8-6-11;3*1-8(2)10(4)11-5-6-12-9(3)7-11;3*1-8(2)9(3)11-6-4-10(12)5-7-11;1-8(2)9(3)11-6-4-5-10(12)7-11;1-9(2)8-11-6-4-10(3)5-7-11;3*1-8(2)9(3)10-4-6-11-7-5-10;1-7(2)4-9(3)8-5-10-6-8;1-8(2)7-9-3-5-10-6-4-9;1-7(2)10-8-3-5-9-6-4-8/h10H,6-9H2,1-5H3;9,11H,5-8H2,1-4H3;9H,5-8H2,1-4H3;3*8-10H,5-7H2,1-4H3;4*8-10,12H,4-7H2,1-3H3;9H,4-8H2,1-3H3;3*8-9H,4-7H2,1-3H3;7-8H,4-6H2,1-3H3;8H,3-7H2,1-2H3;7-8H,3-6H2,1-2H3/t;;;2*9-,10?;;2*9-;;9-,10-;;2*9-;;;;/m...10.10.1.10..../s1
InChIKeyAFMJICVIJWBHNX-OUKPIGSSSA-N
MW2783.62 g/mol
LogP24.47
Rot. Bonds35

About 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine

4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine (PubChem CID 157098487) has the molecular formula C161H341N19O15 and a molecular weight of 2783.62 g/mol. Its IUPAC name is 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine.

Molecular Properties

Compound Name4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine
PubChem CID157098487
Molecular FormulaC161H341N19O15
Molecular Weight2783.62 g/mol
Exact Mass2781.65
IUPAC Name4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine
SMILESCC(C)C(C)(C)N1CCOCC1.CC(C)C(C)N1CCC(O)CC1.CC(C)C(C)N1CCOCC1.CC(C)C(C)N1CCO[C@@H](C)C1.CC(C)C(C)N1CCO[C@H](C)C1.CC(C)CN(C)C1COC1.CC(C)CN1CCN(C)CC1.CC(C)CN1CCN(C)CC1(C)C.CC(C)CN1CCNCC1(C)C.CC(C)CN1CCOCC1.CC(C)OC1CCOCC1.CC(C)[C@@H](C)N1CCC(O)CC1.CC(C)[C@@H](C)N1CCC[C@@H](O)C1.CC(C)[C@@H](C)N1CCOCC1.CC(C)[C@H](C)N1CCC(O)CC1.CC(C)[C@H](C)N1CCOCC1.CC1CN(C(C)C(C)C)CCO1
InChIInChI=1S/C11H24N2.C10H22N2.8C10H21NO.C9H20N2.3C9H19NO.2C8H17NO.C8H16O2/c1-10(2)8-13-7-6-12(5)9-11(13,3)4;1-9(2)7-12-6-5-11-8-10(12,3)4;1-9(2)10(3,4)11-5-7-12-8-6-11;3*1-8(2)10(4)11-5-6-12-9(3)7-11;3*1-8(2)9(3)11-6-4-10(12)5-7-11;1-8(2)9(3)11-6-4-5-10(12)7-11;1-9(2)8-11-6-4-10(3)5-7-11;3*1-8(2)9(3)10-4-6-11-7-5-10;1-7(2)4-9(3)8-5-10-6-8;1-8(2)7-9-3-5-10-6-4-9;1-7(2)10-8-3-5-9-6-4-8/h10H,6-9H2,1-5H3;9,11H,5-8H2,1-4H3;9H,5-8H2,1-4H3;3*8-10H,5-7H2,1-4H3;4*8-10,12H,4-7H2,1-3H3;9H,4-8H2,1-3H3;3*8-9H,4-7H2,1-3H3;7-8H,4-6H2,1-3H3;8H,3-7H2,1-2H3;7-8H,3-6H2,1-2H3/t;;;2*9-,10?;;2*9-;;9-,10-;;2*9-;;;;/m...10.10.1.10..../s1
InChIKeyAFMJICVIJWBHNX-OUKPIGSSSA-N
XLogP24.47
TPSA252.80 Ų
H-Bond Donors5
H-Bond Acceptors34
Rotatable Bonds35
Heavy Atoms195
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002783.62
LogP ≤ 524.47
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1034

Analyze 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine?
The IUPAC name of 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine (CID 157098487) is 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine.
What is the SMILES notation for 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine?
The canonical SMILES for 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine is CC(C)C(C)(C)N1CCOCC1.CC(C)C(C)N1CCC(O)CC1.CC(C)C(C)N1CCOCC1.CC(C)C(C)N1CCO[C@@H](C)C1.CC(C)C(C)N1CCO[C@H](C)C1.CC(C)CN(C)C1COC1.CC(C)CN1CCN(C)CC1.CC(C)CN1CCN(C)CC1(C)C.CC(C)CN1CCNCC1(C)C.CC(C)CN1CCOCC1.CC(C)OC1CCOCC1.CC(C)[C@@H](C)N1CCC(O)CC1.CC(C)[C@@H](C)N1CCC[C@@H](O)C1.CC(C)[C@@H](C)N1CCOCC1.CC(C)[C@H](C)N1CCC(O)CC1.CC(C)[C@H](C)N1CCOCC1.CC1CN(C(C)C(C)C)CCO1.
What is the InChIKey of 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine?
The InChIKey is AFMJICVIJWBHNX-OUKPIGSSSA-N. The full InChI is InChI=1S/C11H24N2.C10H22N2.8C10H21NO.C9H20N2.3C9H19NO.2C8H17NO.C8H16O2/c1-10(2)8-13-7-6-12(5)9-11(13,3)4;1-9(2)7-12-6-5-11-8-10(12,3)4;1-9(2)10(3,4)11-5-7-12-8-6-11;3*1-8(2)10(4)11-5-6-12-9(3)7-11;3*1-8(2)9(3)11-6-4-10(12)5-7-11;1-8(2)9(3)11-6-4-5-10(12)7-11;1-9(2)8-11-6-4-10(3)5-7-11;3*1-8(2)9(3)10-4-6-11-7-5-10;1-7(2)4-9(3)8-5-10-6-8;1-8(2)7-9-3-5-10-6-4-9;1-7(2)10-8-3-5-9-6-4-8/h10H,6-9H2,1-5H3;9,11H,5-8H2,1-4H3;9H,5-8H2,1-4H3;3*8-10H,5-7H2,1-4H3;4*8-10,12H,4-7H2,1-3H3;9H,4-8H2,1-3H3;3*8-9H,4-7H2,1-3H3;7-8H,4-6H2,1-3H3;8H,3-7H2,1-2H3;7-8H,3-6H2,1-2H3/t;;;2*9-,10?;;2*9-;;9-,10-;;2*9-;;;;/m...10.10.1.10..../s1.
What are the key properties of 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine?
4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine has a molecular weight of 2783.62 g/mol, XLogP of 24.47, 35 rotatable bonds, 5 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(2,3-dimethylbutan-2-yl)morpholine;2,2-dimethyl-1-(2-methylpropyl)piperazine;4-[(2R)-3-methylbutan-2-yl]morpholine;4-[(2S)-3-methylbutan-2-yl]morpholine;4-(3-methylbutan-2-yl)morpholine;1-[(2R)-3-methylbutan-2-yl]piperidin-4-ol;1-[(2S)-3-methylbutan-2-yl]piperidin-4-ol;1-(3-methylbutan-2-yl)piperidin-4-ol;(3R)-1-[(2R)-3-methylbutan-2-yl]piperidin-3-ol;(2R)-2-methyl-4-(3-methylbutan-2-yl)morpholine;(2S)-2-methyl-4-(3-methylbutan-2-yl)morpholine;2-methyl-4-(3-methylbutan-2-yl)morpholine;N-methyl-N-(2-methylpropyl)oxetan-3-amine;1-methyl-4-(2-methylpropyl)piperazine;4-(2-methylpropyl)morpholine;4-propan-2-yloxyoxane;2,2,4-trimethyl-1-(2-methylpropyl)piperazine is sourced from PubChem (CID 157098487), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).